$14m in the tin will get burned through very quickly.
I don't have a problem with a raise, but let it be to specialist US or European fund managers. For too long DXB has had to rely on scratchings from small broking houses.
I've been invested in DXB for well over a decade, and welcomed the recent changes in CMO. Ideally we'll see some further changes to the C suite team and Chair to inject some Nth American experience to the team towards the push to commercialise the science.
If it's a mickey mouse domestic raise of <$10m I'll view it as a failed opportunity.
$14m in the tin will get burned through very quickly. I don't...
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
-0.015(2.63%) |
Mkt cap ! $305.1M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 58.5¢ | 54.0¢ | $3.231M | 5.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1118 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 239062 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |